BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 36483739)

  • 1. New insight into the management of renal excretion and hyperuricemia: Potential therapeutic strategies with natural bioactive compounds.
    Yang B; Xin M; Liang S; Xu X; Cai T; Dong L; Wang C; Wang M; Cui Y; Song X; Sun J; Sun W
    Front Pharmacol; 2022; 13():1026246. PubMed ID: 36483739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urate Transporters in the Kidney: What Clinicians Need to Know.
    Chung S; Kim GH
    Electrolyte Blood Press; 2021 Jun; 19(1):1-9. PubMed ID: 34290818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances on uric acid transporters.
    Xu L; Shi Y; Zhuang S; Liu N
    Oncotarget; 2017 Nov; 8(59):100852-100862. PubMed ID: 29246027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uricosuric targets of tranilast.
    Mandal AK; Mercado A; Foster A; Zandi-Nejad K; Mount DB
    Pharmacol Res Perspect; 2017 Apr; 5(2):e00291. PubMed ID: 28357121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olsalazine Sodium Increases Renal Urate Excretion by Modulating Urate Transporters in Hyperuricemic Animals.
    Niu Y; Yang P; Li H; Li Q; Lin H; Gao L; Li L
    Biol Pharm Bull; 2020 Nov; 43(11):1653-1659. PubMed ID: 32863294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: potential role of remote sensing and signaling.
    Bhatnagar V; Richard EL; Wu W; Nievergelt CM; Lipkowitz MS; Jeff J; Maihofer AX; Nigam SK
    Clin Kidney J; 2016 Jun; 9(3):444-53. PubMed ID: 27274832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of mechanism underlying hypouricemic effect of glucosyl hesperidin.
    Ota-Kontani A; Hirata H; Ogura M; Tsuchiya Y; Harada-Shiba M
    Biochem Biophys Res Commun; 2020 Jan; 521(4):861-867. PubMed ID: 31711647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eggshell Membrane Ameliorates Hyperuricemia by Increasing Urate Excretion in Potassium Oxonate-Injected Rats.
    Sung YY; Kim DS
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.
    Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J
    Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DKB114, A Mixture of
    Lee YS; Kim SH; Yuk HJ; Kim DS
    Nutrients; 2018 Sep; 10(10):. PubMed ID: 30274153
    [No Abstract]   [Full Text] [Related]  

  • 11. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats.
    Chen X; Ge HZ; Lei SS; Jiang ZT; Su J; He X; Zheng X; Wang HY; Yu QX; Li B; Lv GY; Chen SH
    Biomed Pharmacother; 2020 Dec; 132():110765. PubMed ID: 33120237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological evaluation of a novel skeleton compound isobavachin (4',7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity.
    Zhao Z; Luo J; Liao H; Zheng F; Chen X; Luo J; Chen Y; Zhao K; Zhang S; Tian J; Wu T; Li Y; Li L; Yang Y; Lin C; Zhang Q; Tian Y; Pang J
    Bioorg Chem; 2023 Apr; 133():106405. PubMed ID: 36753966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.
    Miner JN; Tan PK; Hyndman D; Liu S; Iverson C; Nanavati P; Hagerty DT; Manhard K; Shen Z; Girardet JL; Yeh LT; Terkeltaub R; Quart B
    Arthritis Res Ther; 2016 Oct; 18(1):214. PubMed ID: 27716403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent approaches to gout drug discovery: an update.
    Otani N; Ouchi M; Kudo H; Tsuruoka S; Hisatome I; Anzai N
    Expert Opin Drug Discov; 2020 Aug; 15(8):943-954. PubMed ID: 32329387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice.
    Chen G; Tan ML; Li KK; Leung PC; Ko CH
    J Ethnopharmacol; 2015 Dec; 175():14-20. PubMed ID: 26344851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apical voltage-driven urate efflux transporter NPT4 in renal proximal tubule.
    Jutabha P; Anzai N; Wempe MF; Wakui S; Endou H; Sakurai H
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1302-11. PubMed ID: 22132991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saponins extracted from Dioscorea collettii rhizomes regulate the expression of urate transporters in chronic hyperuricemia rats.
    Zhu L; Dong Y; Na S; Han R; Wei C; Chen G
    Biomed Pharmacother; 2017 Sep; 93():88-94. PubMed ID: 28624426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihyperuricemic effect of mangiferin aglycon derivative J99745 by inhibiting xanthine oxidase activity and urate transporter 1 expression in mice.
    Qin Z; Wang S; Lin Y; Zhao Y; Yang S; Song J; Xie T; Tian J; Wu S; Du G
    Acta Pharm Sin B; 2018 Mar; 8(2):306-315. PubMed ID: 29719791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia.
    Sun HL; Wu YW; Bian HG; Yang H; Wang H; Meng XM; Jin J
    Front Pharmacol; 2021; 12():667753. PubMed ID: 34335246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.